Tevogen Inc. Common Stock
TVGN
62 hedge funds and large institutions have $267M invested in Tevogen Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 62 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
1.55% more ownership
Funds ownership: 0% → 1.55% (+1.6%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Saba Capital Management
New York
|
+$31.4M |
| 2 |
CCP
Corbin Capital Partners
New York
|
+$23.1M |
| 3 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$13.9M |
| 4 |
LA
Linden Advisors
New York
|
+$12.9M |
| 5 |
MI
MMCAP International
Grand Cayman,
Cayman Islands
|
+$12.9M |
Top Sellers
TVGN Hedge Fund Activity: Q1 2022 in Review
62 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Tevogen Inc. Common Stock (TVGN) for Q1 2022, worth a combined $267M.
Buyers outnumbered sellers: 62 funds opened new TVGN positions and 0 closed out — a net gain of 62 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Saba Capital Management, opening a new position worth an estimated $31.4M.
- 62 institutional investors held Tevogen Inc. Common Stock (TVGN) as of Q1 2022, up from 0 in Q4 2021.
- Funds reported $267M of Tevogen Inc. Common Stock stock for Q1 2022.
- 62 funds opened new Tevogen Inc. Common Stock positions in Q1 2022 and 0 closed out, a net change of +62 holders.
- The largest Tevogen Inc. Common Stock buyer in Q1 2022 was Saba Capital Management, an estimated $31.4M added.
Based on aggregated 13F filings for Q1 2022.